Emergent BioSolutions Inc (NYSE:EBS)

98.74
Delayed Data
As of Feb 24
 -0.06 / -0.06%
Today’s Change
46.37
Today|||52-Week Range
137.61
+10.20%
Year-to-Date
Why Emergent BioSolutions Stock Is Sliding Today
Feb 19 / MotleyFool.com - Paid Partner Content
Emergent BioSolutions Inc (EBS) Q4 2020 Earnings Call Transcript
Feb 19 / MotleyFool.com - Paid Partner Content
Emergent (EBS) Beats on Q4 Earnings, Misses on Revenues
Feb 19 / Zacks.com - Paid Partner Content
Vaxart (VXRT) to Report Q4 Earnings: What's in the Cards?
Feb 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close98.80
Today’s open93.14
Day’s range96.34 - 99.11
Volume564,347
Average volume (3 months)569,255
Market cap$5.5B
Data as of 3:59pm ET, 02/24/2021

Growth & Valuation

Earnings growth (last year)+447.10%
Earnings growth (this year)+16.26%
Earnings growth (next 5 years)+13.50%
Revenue growth (last year)+40.63%
P/E ratio17.4
Price/Sales3.10
Price/Book3.78

Competitors

----
ALLOAllogene Therapeutic...+0.67+1.98%
----
BPMCBlueprint Medicines ...+0.34+0.35%
Data as of 3:59pm ET, 02/24/2021

Financials

Next reporting dateMay 6, 2021
EPS forecast (this quarter)$1.33
Annual revenue (last year)$1.6B
Annual profit (last year)$305.1M
Net profit margin19.62%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Gaithersburg, Maryland

Forecasts